Los Angeles Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-153,161
Closed -$9.68M 2469
2025
Q4
$9.68M Sell
153,161
-36,251
-19% -$2.91M 0.03% 233
2025
Q3
$10.4M Buy
189,412
+54,414
+40% +$2.72M 0.04% 262
2025
Q2
$7.17M Buy
+134,998
New +$6.86M 0.03% 272
2024
Q4
Sell
-62,062
Closed -$4.23M 1158
2024
Q3
$4.23M Buy
+62,062
New +$3.5M 0.02% 332
2024
Q2
Sell
-7,214
Closed -$498K 1205
2024
Q1
$498K Sell
7,214
-10,928
-60% -$691K ﹤0.01% 873
2023
Q4
$1.34M Buy
+18,142
New +$1.19M 0.01% 576
2023
Q2
Sell
-5,640
Closed -$382K 1206
2023
Q1
$382K Buy
+5,640
New +$363K ﹤0.01% 937
2021
Q3
Sell
-1,899
Closed -$236K 1509
2021
Q2
$236K Sell
1,899
-2,060
-52% -$246K ﹤0.01% 1452
2021
Q1
$522K Sell
3,959
-2,754
-41% -$377K ﹤0.01% 1201
2020
Q4
$889K Buy
6,713
+3,592
+115% +$434K ﹤0.01% 989
2020
Q3
$318K Buy
+3,121
New +$270K ﹤0.01% 1251
2020
Q2
Sell
-16,220
Closed -$941K 1470
2020
Q1
$941K Hold
16,220
0.01% 725
2019
Q4
$1.5M Buy
16,220
+12,335
+318% +$1.08M 0.01% 719
2019
Q3
$351K Sell
3,885
-270
-6% -$30.8K ﹤0.01% 1087
2019
Q2
$490K Sell
4,155
-51,402
-93% -$5.18M ﹤0.01% 1046
2019
Q1
$4.81M Buy
55,557
+50,470
+992% +$4.3M 0.03% 444
2018
Q4
$321K Sell
5,087
-210
-4% -$14.4K ﹤0.01% 1079
2018
Q3
$418K Sell
5,297
-29,065
-85% -$1.9M ﹤0.01% 1149
2018
Q2
$2.06M Sell
34,362
-44,820
-57% -$2.41M 0.01% 685
2018
Q1
$3.19M Buy
79,182
+3,040
+4% +$148K 0.02% 522
2017
Q4
$4M Buy
76,142
+56,887
+295% +$3.04M 0.02% 496
2017
Q3
$907K Buy
+19,255
New +$775K 0.01% 844

Other funds holding EXAS

Los Angeles Capital Management's EXAS Position: Q1 2026 in Review

Los Angeles Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 153,161 shares — an estimated $9.68M sold.

Los Angeles Capital Management first reported a position in EXAS in Q3 2017 and held it in 22 quarters. The position peaked at $10.4M in Q3 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Los Angeles Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 153,161 Exact Sciences shares in Q1 2026, an estimated $9.68M.
  • Los Angeles Capital Management first reported a position in Exact Sciences in Q3 2017 and held it in 22 quarters.
  • Los Angeles Capital Management's Exact Sciences position peaked at $10.4M in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.